Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-046846

Chief Executive Officer sold 50,000 shares at $41.35 ($2,067,500)

  • Chief Executive Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2020-08-13 Option exercise +50,000 $9.90 $495,000 2,655,237 D
Anzalone Christopher Richard Chief Executive Officer 2020-08-13 Sale −50,000 $41.35 $2,067,500 2,605,237 D
Derivatives
Anzalone Christopher Richard Chief Executive Officer 2020-08-13 Option exercise · Stock Option (right to buy) −50,000 895,543 D
Open-market sales · 50,000 sh · avg $41.35 · $2,067,500
Loading xslF345X03/doc4.xml…